Medical News

RSS

Methotrexate re-use in rheumatoid arthritis is frequently effective despite earlier failures

A second course of methotrexate, the most commonly used drug to treat rheumatoid arthritis, is effective in nearly half of studied patients for whom a previous treatment with the drug was ineffective.

27 Feb 2006

New generation gold-based drugs for treating rheumatoid arthritis

Gold compounds have been used for the treatment of rheumatoid arthritis and other autoimmune diseases for more than 75 years, but until now, how the metals work has been a mystery.

27 Feb 2006

Steroids trigger long lasting aggression in teens

According to a U.S. study steroids may have a lasting effect on teenagers' brains, and could even flip the adolescent brain's switch for aggression which may last for at least two years.

27 Feb 2006

Providing research participants with findings from cancer trials: not quite as simple as it sounds

A recent push to share study findings with patients after they complete treatment in clinical trials may actually do more harm than good by exposing study participants to unnecessary psychological stress, according to a new commentary.

27 Feb 2006

Combination therapy improves Acquired Immunodeficiency Syndrome-Related Lymphoma outcome

Combining aggressive HIV therapy and chemotherapy significantly improves the survival rates of HIV-positive men and women treated for lymphoma, according to a new study.

27 Feb 2006

Waking up the inner sleeping beauty of companies

Studies in corporate responsibility (CR) have found that many large companies seem to fulfil the psychiatric criteria for psychopaths.

27 Feb 2006

Study associates chronic, severe inflammation with increased lymphoma risk among RA patients

An inflammatory disease of the immune system, rheumatoid arthritis (RA) is associated with increased occurrence of lymphoma--or cancers of the lymphatic system, which plays an integral role in the body's ability to fight infection.

27 Feb 2006

Study associates meniscal damage with advanced cartilage loss in early osteoarthritis

Cartilage loss is a major component of osteoarthritis (OA), a joint disease that affects over 20 million Americans. In knee OA, cartilage loss is influenced by knee injury, as well as obesity and age. Every healthy knee is supported and protected by a pair of meniscus.

27 Feb 2006

Chromium industry withheld data from the U.S. government

According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.

27 Feb 2006

Potatoes increase risk of diabetes

Researchers at Harvard University are warning that people who love to eat potatoes run the risk of diabetes.

27 Feb 2006

Viagra could cure Crohn's disease

Crohn's disease is a chronic inflammatory bowel disorder which causes ulcerations in the gut and can make digesting food painful.

27 Feb 2006

Parents lose court battle over future of gravely ill child

A high court in the UK has ruled that doctors treating a seriously ill two-year-old girl can let her die naturally.

27 Feb 2006

Virus could trigger prostate cancer

A team of researchers from Cleveland Clinic and the University of California, San Francisco have discovered a new virus in prostate tumours.

27 Feb 2006

French vaccinate millions of free range birds as farm becomes first victim of bird flu

A farm in eastern France has become the first domestic victim of the H5N1 strain of bird flu in the European Union.

27 Feb 2006

Takeda wins patent infringement case

Takeda Pharmaceutical Company Limited and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc. have announced that Takeda's intellectual property rights have been successfully asserted against generic manufacturers seeking to challenge Takeda's patent rights to ACTOS (pioglitazone HCl).

24 Feb 2006

Bangladesh launches measles vaccination campaign

The Bangladesh measles vaccination campaign to be held for three weeks between February 25 and March 16 will mark the Measles Initiative's expansion into Asia after recently celebrating the success of the Initiative's original goal of reducing measles deaths by vaccinating 200 million children in more than 40 African countries

24 Feb 2006

Combination of glucosamine and chondroitin sulfate may be effective in some patients with moderate-to-severe knee pain

Offering hope for millions of people who suffer the most from osteoarthritis, a study published in the New England Journal of Medicine (NEJM) has found that the combined use of two dietary supplements - glucosamine and chondroitin - provided significant pain relief from the most common form of arthritis.

24 Feb 2006

Medical News

Methotrexate re-use in rheumatoid arthritis is frequently effective despite earlier failures

New generation gold-based drugs for treating rheumatoid arthritis

Steroids trigger long lasting aggression in teens

Providing research participants with findings from cancer trials: not quite as simple as it sounds

Combination therapy improves Acquired Immunodeficiency Syndrome-Related Lymphoma outcome

Waking up the inner sleeping beauty of companies

Study associates chronic, severe inflammation with increased lymphoma risk among RA patients

Study associates meniscal damage with advanced cartilage loss in early osteoarthritis

Chromium industry withheld data from the U.S. government

Potatoes increase risk of diabetes

Viagra could cure Crohn's disease

Parents lose court battle over future of gravely ill child

Virus could trigger prostate cancer

French vaccinate millions of free range birds as farm becomes first victim of bird flu

Takeda wins patent infringement case

Bangladesh launches measles vaccination campaign

Combination of glucosamine and chondroitin sulfate may be effective in some patients with moderate-to-severe knee pain

$1 million of mesothelioma research funding

Baxter and Chiron awarded UK gov contract for H5N1 vaccine

Angiotech to appeal judgement regarding UK patent

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Latest News